Osteogenesis Imperfecta and Implant Treatment?
I have a 67 year old patient who wants implant supported replacement of failed upper anterior bridgework. He is fit and well, but for having Ostegenesis Imperfecta Type 1 and is on Alendronic Acid. Published research is (perhaps unsurprisingly) sparse and largely anecdotal. It would appear that success rate may lower, but my question is, is Ostegenesis Imperfecta (OI) considered to be a comorbidity when considering Alendronate? Is he at greater risk of the dreaded MRONJ? If the worst that is likely to happen is implant failure, I would not be leaving him significantly worse off, but a rotted maxilla is another matter! Thoughts?
Note: Osteogenesis Imperfecta (OI) is a genetic bone disorder characterized by fragile bones that break easily. It is also known as “brittle bone disease.” The term literally means “bone that is imperfectly made from the beginning of life.” A person is born with this disorder and is affected throughout his or her life time. Learn more